Is [18F]fluorodeoxyglucose Positron Emission Tomography the Ultimate Tool for Response and Prognosis Assessment?
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 21 (5) , 855-869
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.Blood, 2005
- Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest RadiotherapyJournal of Clinical Oncology, 2004
- Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated With Radiation TherapyJAMA, 2003
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 YearsJournal of Clinical Oncology, 2002
- Second Malignant Neoplasms After Treatment for Hodgkin’s Disease in Childhood or AdolescenceJournal of Clinical Oncology, 2000
- Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young AdulthoodJournal of Clinical Oncology, 2000
- Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at TreatmentJournal of Clinical Oncology, 2000
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseNew England Journal of Medicine, 1987